Artal Participations S.a r.l. - 05 Dec 2024 Form 3 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director, 10%+ Owner
Signature
ARTAL PARTICIPATIONS S.A R.L., By: /s/ Pierre Claudel, Name: Pierre Claudel Title: Manager
Issuer symbol
LXRX
Transactions as of
05 Dec 2024
Net transactions value
$0
Form type
3
Filing time
16 Dec 2024, 19:00:08 UTC
Next filing
19 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LXRX Common Stock 136,180,481 05 Dec 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 5, 2024, Artal International S.C.A. transferred 136,180,481 shares of common stock, $0.001 par value per share (the "Common Stock") to its wholly owned subsidiary, Artal Participations S.a r.l. The sole shareholder of Artal Participations S.a r.l. is Artal International S.C.A. The managing partner of Artal International S.C.A. is Artal International Management S.A. The sole stockholder of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting.
F2 The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Reporting Person states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Remarks:

Invus Public Equities, L.P. directly holds 3,516,214 shares of Common Stock, Invus, L.P. directly holds 35,402,689 shares of Common Stock and Invus US Partners LLC directly holds 5,451,204 shares of Common Stock, which securities are reported on separate Form 4 filings. For purposes of Section 16 of the Exchange Act, the Reporting Person may be deemed to be a director by deputization of the Issuer by virtue of Invus, L.P.'s right to designate certain members of the Issuer's board of directors pursuant to a stockholders' agreement between the Issuer and Invus, L.P.